Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of LCA-Vision, Inc. Stockholders
NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of LCA-Vision, Inc. (“LCA-Vision” or the “Company”) (NASDAQ:LCAV) concerning the proposed acquisition of the Company by PhotoMedex, Inc. (“PhotoMedex”) (NASDAQ: PHMP). Under the terms of the definitive merger agreement, LCA-Vision stockholders will receive $5.37 in cash for each share of LCA-Vision owned, valuing the transaction at approximately $106.4 million.
The investigation concerns whether the LCA-Vision Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values LCA-Vision’s common stock.
If you are an LCA-Vision stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at email@example.com, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.